A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity

Karina Pino-Lagos, Yanxia Guo, Chrysothemis Brown, Matthew P. Alexander, Raúl Elgueta, Kathryn A. Bennett, Victor De Vries, Elizabeth Nowak, Rune Blomhoff, Shanthini Sockanathan, Roshantha A. Chandraratna, Ethan Dmitrovsky, Randolph J. Noelle

Research output: Contribution to journalArticle


It is known that vitamin A and its metabolite, retinoic acid (RA), are essential for host defense. However, the mechanisms for how RA controls inflammation are incompletely understood. The findings presented in this study show that RA signaling occurs concurrent with the development of inflammation. In models of vaccination and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporally and spatially restricted to the site of inflammation. Conditional ablation of RA signaling in T cells significantly interferes with CD4+ T cell effector function, migration, and polarity. These findings provide a new perspective of the role of RA as a mediator directly controlling CD4+ T cell differentiation and immunity.

Original languageEnglish (US)
Pages (from-to)1767-1775
Number of pages9
JournalJournal of Experimental Medicine
Issue number9
StatePublished - Aug 29 2011


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Pino-Lagos, K., Guo, Y., Brown, C., Alexander, M. P., Elgueta, R., Bennett, K. A., De Vries, V., Nowak, E., Blomhoff, R., Sockanathan, S., Chandraratna, R. A., Dmitrovsky, E., & Noelle, R. J. (2011). A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. Journal of Experimental Medicine, 208(9), 1767-1775. https://doi.org/10.1084/jem.20102358